Please wait a minute...
浙江大学学报(医学版)  2013, Vol. 42 Issue (5): 504-510    DOI: 10.3785/j.issn.1008-9292.2013.05.005
论著     
木犀草素对人肝癌细胞HepG2的促凋亡作用
王远鹏,周亮,龚兴国
浙江大学生命科学学院生物化学所,浙江 杭州 310058
Pro-apoptotic effects of luteolin on hepatoma HepG2 cells
WANG Yuan-Peng, ZHOU Liang, GONG Xing-Guo
Institute of Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou 310058, China
 全文: PDF(1379 KB)   HTML (
摘要:
目的:研究木犀草素(Luteolin)对人肝癌细胞HepG2的生长抑制与促凋亡作用机制。
方法:用梯度浓度木犀草素作用于多种肿瘤细胞,以MTT法检测药物对细胞的生长抑制作用,以流式细胞术检测HepG2细胞内活性氧水平,以Annexin V-FITC/PI双染法利用流式细胞术检测HepG2细胞凋亡情况,以Western-blot检测HepG2细胞凋亡相关通路蛋白表达水平。
结果:木犀草素对多种肿瘤细胞的生长具有浓度和时间依赖的抑制作用(72 h最高抑制率超过60%),并能有效降低HepG2细胞内活性氧水平(约降低41.11%)。木犀草素作用下HepG2细胞凋亡率可达14.43%左右。木犀草素能够降低HepG2细胞内iASPP蛋白表达水平并上调p53与ASPP2蛋白表达。
结论:木犀草素能够抑制肿瘤细胞生长,降低HepG2细胞内活性氧水平,并调节细胞内相关凋亡通路蛋白水平,从而诱导HepG2细胞凋亡。
关键词: 木犀草素癌,肝细胞肝肿瘤细胞凋亡活性氧肿瘤抑制蛋白质p53流式细胞术肿瘤细胞,培养的    
Abstract:

Objective: To investigate the effect of luteolin on cell growth and apoptosis of HepG2 cells in vitro.
Methods: Cultured HepG2,HL60,A549 and LO2 cells were treated with luteolin for different doses (0 μg/ml,2.5 μg/ml,10 μg/ml and 20 μg/ml) and varied times (0 h,24 h,48 h and 72 h).Cell viability was measured with MTT assay and IC50 was calculated.The reactive oxygen species (ROS) levels in HepG2 cells treated with luteolin for 6 h and 12 h were measured with flow cytometry.Cell apoptosis of HepG2 cells treated with luteolin for 24h was examined with flow cytometry and Annexin V-FITC/PI.Expression levels of apoptosis pathway proteins (p53,ASPP2 and iASPP) in HepG2 cells were detected with western blot and the dose and time-effect was analyzed.
Results: Luteolin effectively inhibited tumor cell proliferation in a dose- and time-dependent manner,and the inhibition rates of 20μg/ml Luteolin for 72h were 39.34%,62.90%,57.57% and 62.90% to LO2,HepG2,HL60 and A549 cells,respectively.The intracellular ROS level was decreased in HepG2 cells by 13.88% and 41.11% after being treated with luteolin for 6 h and 12 h,respectively.The apoptosis rate of HepG2 cells treated with luteolin for 24 h was 14.43%,and western blot showed that luteolin reduced the expression level of iASPP by 77.07% and up-regulated the expression of p53 by 179.37% and ASPP2 by 725.02% in HepG2 cells treated with luteolin for 12 h.
Conclusion: Luteolin has anti-proliferative and pro-apoptotic activity on hepatoma HepG2 cells,which is associated with the altered expression of pro-apoptotic factors and decreased ROS level in HepG2 cells.

Key words: Luteolin    Carcinoma, Hepatocellular    Liver neoplasms    Apoptosis    Reactive oxygen species    Tumor suppressor protein p53    Flow cytometry    Tumor cells, Cultured
收稿日期: 2012-09-14 出版日期: 2013-09-25
:  R 34  
基金资助:

国家自然科学基金(30900760);浙江省科技计划项目(2006C12084).

通讯作者: 龚兴国(1955-),男,研究员,主要从事重要药用蛋白和临床诊断用酶的基因工程研究;E-mail:gongxg@zju.edu.cn   
作者简介: 王远鹏(1986-),男,硕士研究生,主要从事信号传导通路和作用机制研究;E-mail:wangyuanpeng1986@yahoo.com.cn
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
王远鹏
周亮
龚兴国

引用本文:

王远鹏, 周亮, 龚兴国. 木犀草素对人肝癌细胞HepG2的促凋亡作用[J]. 浙江大学学报(医学版), 2013, 42(5): 504-510.

WANG Yuan-Peng, ZHOU Liang, GONG Xing-Guo. Pro-apoptotic effects of luteolin on hepatoma HepG2 cells. Journal of ZheJiang University(Medical Science), 2013, 42(5): 504-510.

链接本文:

https://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2013.05.005        https://www.zjujournals.com/med/CN/Y2013/V42/I5/504

[1] ASHOKKUMAR P,SUDHANDIRAN G.Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis [J].Biomed Pharmacother,2008,62(9):590-597.
[2] JANG S,KELLEY K W,JOHNSON R W.Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1 [J].Proc Nat Acad Sci U S A,2008,105(21):7534-7539.
[3] MEHLA R,BIVALKAR-MEHLA S,CHAUHAN A.A Flavonoid,Luteolin,Cripples HIV-1 by Abrogation of Tat Function [J].Plos One,2011,6(11).
[4] BAGLI E,STEFANIOTOU M,MORBIDELLI L,et al.Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity [J].Cancer Res,2004,64(21):7936-7946.
[5] CAI X T,YE T M,LIU C,et al.Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells [J].Toxicol in Vitro,2011,25(7):1385-1391.
[6] YAN J Q,WANG Q,ZHENG X L,et al.Luteolin enhances TNF-related apoptosis-inducing ligand′s anticancer activity in a lung cancer xenograft mouse model [J].Biochem Biophys Res Communi,2012,417(2):842-846.
[7] YANG S F,YANG W E,CHANG H R,et al.Luteolin induces apoptosis in oral squamous cancer cells [J].J Dent Res,2008,87(4):401-406.
[8] FARIED A,FARIED L S,KATO H,et al.Targeting p53 tumor suppressor to induce apoptosis and cell cycle arrest in esophageal cancer cells by novel sugar-cholestanols compounds [J].Eur J Cancer Suppl,2008,6(9):83.
[9] TRACHOOTHAM D,ALEXANDRE J,HUANG P.Targeting cancer cells by ROS-mediated mechanisms:a radical therapeutic approach? [J].Nat Rev Drug Discov,2009,8(7):579-591.
[10] RAJ L,IDE T,GURKAR A U,et al.Selective killing of cancer cells by a small molecule targeting the stress response to ROS [J].Nature,2011,475(7355):231-234.
[11] ZHOU L,LAI Z T,LU M K,et al.Expression and hydroxylamine cleavage of thymosin alpha 1 concatemer [J].J Biomed Biotechnol,2008,2008:736060.
[12] QIN Y,CHEN F D,ZHOU L,et al.Proliferative and anti-proliferative effects of thymosin alpha 1 on cells are associated with manipulation of cellular ROS levels [J].Chem Biol Interact,2009,180(3):383-388.
[13] FINKEL T.Oxidant signals and oxidative stress [J].Curr Opin Cell Bio,2003,15(2):247-254.
[14] SHI R X,ONG C N,SHEN H M.Protein kinase C inhibition and X-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells [J].Cancer Res,2005,65(17):7815-7823.
[15] ANDO C,TAKAHASHI N,HIRAI S,et al.Luteolin,a food-derived flavonoid,suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation [J].FEBS Lett,2009,583(22):3649-3654.
[16] LEE W J,WU L F,CHEN W K,et al.Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways [J].Chem Biol Interact,2006,160(2):123-133.
[1] 张冬梅,曹琪璐,景临林,赵秀华,马慧萍. PC12细胞低压性缺氧损伤模型的建立[J]. 浙江大学学报(医学版), 2021, 50(5): 614-620.
[2] 宋飞凤,张轶雯,潘宗富,张琪,卢茜璇,黄萍. 白藜芦醇通过上调miR-186-5p表达抑制肝癌细胞迁移、侵袭和上皮-间质转化[J]. 浙江大学学报(医学版), 2021, 50(5): 582-590.
[3] 王金钢,陈春晓,任于晗,周辛欣,俞珊. 二甲双胍通过抑制内质网应激诱导的细胞凋亡改善结肠炎黏膜上皮屏障损伤[J]. 浙江大学学报(医学版), 2021, 50(5): 627-632.
[4] 黄卓群,余夏飞,刘星宇,马康,黄敏华,李芳芳,杨巍,牛建国. 瞬时受体电位 M2抑制剂 A10对缺糖缺氧后复糖复氧细胞的保护作用[J]. 浙江大学学报(医学版), 2021, 50(1): 106-112.
[5] 叶嘉仪,龚恒佩,王凌峰,黄真,仇凤梅,钟晓明. 玄参环烯醚萜苷对氧糖剥夺再灌注细胞模型内质网钙稳态的调控作用[J]. 浙江大学学报(医学版), 2020, 49(6): 705-713.
[6] 李梦瑶,刘盼,柯越海,张雪. 放射性肺损伤中巨噬细胞作用机制的研究进展[J]. 浙江大学学报(医学版), 2020, 49(5): 623-628.
[7] 方娟,潘志成,郭晓纲. INK4基因座中反义非编码RNA调控细胞增殖与凋亡影响动脉粥样硬化的研究进展[J]. 浙江大学学报(医学版), 2020, 49(1): 113-117.
[8] 张军浩,金静华,杨巍. 自噬调控血管平滑肌细胞功能在颅内动脉瘤形成和破裂中的作用[J]. 浙江大学学报(医学版), 2019, 48(5): 552-559.
[9] 张丹丹,王军梅. 胎儿肝血管瘤的产前影像学诊断和管理[J]. 浙江大学学报(医学版), 2019, 48(4): 439-445.
[10] 马竞, 何文龙, 高重阳, 余瑞云, 薛鹏, 牛永超. 木瓜苷通过抑制NF-κB P65/TNF-α通路活性减轻小鼠脑缺血再灌注诱导的组织损伤[J]. 浙江大学学报(医学版), 2019, 48(3): 289-295.
[11] 范苗, 董淑敏, 邹心怡, 郑博远, 黄玉润, 王健达, 曾玲晖. 癫痫鼠外周血磷酸化S6蛋白检测及意义[J]. 浙江大学学报(医学版), 2019, 48(3): 303-309.
[12] 杨坤,胡晓晟. 微小RNA-21在心脏疾病中的研究进展[J]. 浙江大学学报(医学版), 2019, 48(2): 214-218.
[13] 梁刚, 牛育苗, 李一涵, 魏安怡, 董静尹, 曾玲晖. 雷帕霉素在大鼠局灶性脑缺血再灌注后24 h给药对脑损伤的保护作用[J]. 浙江大学学报(医学版), 2018, 47(5): 443-449.
[14] 林卡娜,林美丽,顾莹芬,张顺国,黄诗颖. G蛋白偶联受体17在视网膜神经节细胞缺氧损伤中的作用[J]. 浙江大学学报(医学版), 2018, 47(5): 487-492.
[15] 何佳怡,张信美. 氧化应激在子宫内膜异位症发病机制中的研究进展[J]. 浙江大学学报(医学版), 2018, 47(4): 419-425.